Biological treatments of
OCD
Dr.S.Santhosh Goud
Chairperson;Dr.Ravi Awchar
DSM 5-OCD and related disorders
• OCD
• BDD
• Hoarding disorder
• Trichitillo mania/HPD
• Excoriation/skin picking disorder
• Substance/medication induced OCD
• OCD due to another medical condition
Ocd criteria
DSM 5 criteria
• Presence of obsession/compulsion
• Time consumption>1 hr/clinically
significant distress or impairment
• Rule out role of substance/other medical
condition
• Not due to other mental disorder
• Obsessions are persistent, uncontrollable
thoughts, impulses, or images that are
intrusive, unwanted and disturbing. They
cause anxiety or discomfort that
significantly interferes with normal life
• Individuals who have OCD feel compelled
to perform repetitive actions called
compulsions, or rituals, in an attempt to
relieve the distress caused by the
obsessions
Neuro biology of OCD
Emotional brain controls the reasoning
brain
The part of the brain responsible for ocd,
functions very much on the same
emotional level as that of a two year old.
Reasoned argument is, therefore,
pointless…!
Loss of filtering
• Thalamus-sensory gating
• Caudate nuleus-thought filtering
• Orbito frontal cortex-combines thoughts
and emotions
• Cingulate gyrus in the middle of brain
• Helps in shifting attention from one
thought/behavior to another
• CG also acts as a signaling center for
danger so forces to do compulsion
Ocd santhosh final
Structural changes
• Volume reduction of the OFC
• Cingulate cortex
• Decreased OFC with increased thalamic
volume constant finding in refractory
cases
Functional studies
• FDG-PET increased glucose metabolism
in ofc,caudate,thalamus,pfc and acc
Neurotransmitter changes
• Serotonin
• Autoreceptors (5HT1D) require higher
SSRI dose
• Role of 5HT 7 receptors
Dopamine
• Quinpirole treated rats-compulsive
checking
Glutamate
• OCD is a hyperglutaminergic state of
prefrontal brain-(Carlsson)
• SSRI, Clomipramine do regulate this
Glutamate regulators used in resistant
cases
Neuroimmunology
• Auto immunity to basal ganglia
• Sydenham chorea, PANDAS
• D8/17 B lymphocyte antigen more prone
• Plasmapheresis, iv immunogloblin useful
Genetics
• Higher concordance in monozygotic twins
• 5HTTLPR
• Role of DRD4 variant
• COMT variation
• polymorphisms of MAOA genes
Course and prognosis
• Adolescent onset~65%
• <15% after 35 yrs of age
• Nearly 70 percent of patients report a
continuous course of symptoms, and 23
percent experience a waxing and waning
course
• Average time to treatment after meeting
diagnostic criteria for OCD is 11 years
(The Brown Longitudinal Obsessive
Naturalistic follow up studies from pre-sri/cbt
era
• Improvement in 66% recovery in 32%
(lewis,1936)
Pollitt study-101 patients
• 3 months-15yrs(mean 3.4yrs) out come
• 34 leucotomized
• 67 non leucotomized
• 40% good response;most of them with in 2
years
• Most of the patients having waxing waning
• Skoog &skoog study 1999
• 250 patients admitted between 1947-1953
• Reexamined between 1989-1993
• 75 died,32 lost follow up
• 144 patients data could be collected
• Shneiders ocd criteria
• Improvement in 83%
• Recovery 48%
• Complete recovery 20% subclinical
symptoms 28%
• 38% recovered in first decade
• Hal of them had illness for >30yrs
Recent studies
• Full remission 20-45%(Y-BOCS <3)
• Partial remission 20-55%( 4-14)
• Clinical ocd10-60%(>15)
• 40-60% unsatisfactory response
• Predictors of treatment response..?
• Hoarding disorder poor response to SSRI
• High scores on sexual/religious
obsessions poor response to
SRI/CBT(Matix-colas et al)
• Somatic obsessions had poorer insight
and less response to drugs(expect MAO-I)
Ocd santhosh final
FDA approved drugs
• Anafranil (clomipramine)-c10
• Prozac (fluoxetine)-c7
• Luvox (fluvoxamine)-c8
• Paxil (paroxetine hydrochloride)
• Zoloft (sertraline)-c6
“Off-label" OCD medications
• Celexa (citalopram)
• Lexapro (escitalopram)
• Effexor (venlafaxine)
• Cymbalta (duloxetine)
• Remeron (mirtazapine)
Augmenting agents
• Antipsychotic medications(Risperdal
(risperidone)Zyprexa
(olanzapine)Seroquel (quetiapine))
• Other augmenting agents
• B blocker
• 5HT1 agonist
• Ondansetron
• Riluzole
• Memantine
How to choose the right drug
• Diagnosis;severity;comorbid illness
• Medical history;the potential side effects of
each medication, and the possibility of an
adverse interaction with another drug the
person is taking
drug Starting dose Target
dose(mg/day
)
Usual
Maximum
dose
Occassional
max dose
Fluoxetine 20 40-60 80 120
Sertraline 50 200 200 400
Fluvoxamine 50 200 300 450
Paroxetine 20 40-60 60 100
escitalopram 10 20 40 60
clomipramine 25 100-250 300
Resistence vs refractoriness
• Rauch and Jenike, in 1994, established the
difference between "resistant" and
"refractory" patients.
• They defined as "resistant" those who
participate in a trial with any first-line therapy
and do not have a satisfactory response,
while the "refractory" patients are those who
do not respond appropriately to several
treatments administered in an adequate
manner
• Pallanti et al
• No response -<25% reduction in YBOCS
score CGI-I 4
• Refractory- failure to respond to all
available treatments
• Pseudo resistance..?
Predictors of treatment non-response
• Early age of onset
• Longer ocd
• Mixed ocd
• Sexual obsessions
• Washing compulsons
• Hoarding
• Poor insight
• Schizotypal pd
• Switching to another SSRI(~50%)
• Switch to Clomipramine(upto300mg)
(min 2 SSRI trails;NIMHANS ocd clinic)
• IV Clomipramine (~43%)
• Min 14 infusions
• 250mg/day
• More side effects
• SSRI to venlafaxine or Mirtazepine
Augmentation
• Best evidence with Risperidone(0.5-6mg)
• First doc for augmentation
• Other drugs haloperidol(1.5-
5mg),olanzepine(2.5-20),quetiapine(50-
300)
• Clonazepam(upto 6.5mg)
• Buspirone(60-90mg),
• Nicotine,cbzp,lamotrigene,gabapentine,
reboxetine,psychostimulants,nac,
Aripiprazole less evidence
• Lithium, thyroid,l-tryptophan(2gm)
ineffective;useful for comorbidities
• once-weekly oral morphine sulfate
• Other less well-supported monotherapies
include dextroamphetamine (Dextrostat),
tramadol (Ultram), monoamine oxidase
inhibitors, ondansetron (Zofran)
• When to change augmentation?
• no desired response by 6-8wks
• Augmentation for how long?
Combination strategies
• SSRI and clomipramine
• Superior to switching(Pallanti et al)
• Look for serotonin syndrome
Intensive residential therapy
• IP treatment
• Multidisciplinary approach
• Pharmacotherapy
• Daily CBT 2-4 hours
• Group therapy
Ocd santhosh final
Ocd santhosh final
Other somatic therapies
• r-TMS
• DBS
• ECT
• Vagal stimulation
r-TMS
• Since 1997, in published trials, a total of
110 OCD patients have been treated with
rTMS
• Greenberg et al.inhibition of the prefrontal
activity with rTMS might reduce
obsessive-compulsive symptoms.
• 1) stimulation of the dorsolateral prefrontal
cortex (DLPFC)
• 2) inhibition of the orbitofrontal cortex
(OFC) directly
• 3) inhibition of the supplementary motor
area (SMA).
Deep brain stimulation
• Nucleus accumbens
• Anterior capsule
• Caudate nucleus
• Subthalamic nucleus
ECT
• The primary indication would be the
severe depression with which intractable
OCD is often associated(Bulletin of Clinical
Psychopharmacology
• ECT Use in Refractory Obsessive-Compulsive Disorder Nesrin B.
Tomruk Omer Saatcioglu)
Vagus nerve stimulation
Neurosurgical procedures
Criteria
• Diagnosis by standard criteria
• Severe ocd
• Long standing(>5 yrs)
• At least 3 serotenergic(one should be
clomipramine),2 augmenting agents, for 12
weeks
• Adequate cbt (20hrs)
• Less than 25% improvement with treatment
Procedures
• Anterior capsulotomy
• Anterior cingulotomy
• Subcaudate tractotomy
• Limbic leukotomy(subcaudate tractotomy
with anterior cingulotomy)
Gamma knife capsulotomy safer and non-
invasive
Further reading on psycho surgery in OCD
• Indian J Psychiatry. 2009 Jul-Sep; 51(3):
216–221 Surgical treatment of obsessive
compulsive disorders: Current status
Paresh K. Doshi
Ocd santhosh final
Ocd santhosh final

More Related Content

PPTX
Nms vs ss
PPTX
Different faces of depression
PPTX
Treatment approach to treatment resistant schizophrenia
PPTX
Cardiovascular and metabolic side effects of antipsychotics
PPTX
Recent advances in the management of parkinson disease
PPTX
DBS for Parkinson's disease.
PPTX
Parkinson disease
PPTX
Management of parkinsons disease
Nms vs ss
Different faces of depression
Treatment approach to treatment resistant schizophrenia
Cardiovascular and metabolic side effects of antipsychotics
Recent advances in the management of parkinson disease
DBS for Parkinson's disease.
Parkinson disease
Management of parkinsons disease

What's hot (20)

PPTX
Pharmacotherapy of parkinson disease
PPT
Management of parkinson’s disease
PPTX
PARKINSON’S DISEASE
PPTX
Management of early and advanced parkinson disease
PPTX
Parkinsons disease
PPTX
Immune mediated extrapyramidal disorders
PPTX
PARKINSON DISEASE
PPTX
Advances in Management of Parkinson's Disease
PPTX
Parkinson’s disease clinical research challenges and best practices 2015
PPTX
Management of parkinson’s disease
PDF
Extra-nigral motor scenarios in Parkinson Disease
PPTX
Neuropsychiatric Symptoms of Parkinson Disease
PPT
Invega
PPTX
Management of advanced Parkinson's Disease. dr. Walid Reda Ashour, MD
PPT
Parkinson\'s Disease
PPTX
Parkinson's disease n management
PPTX
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
PPTX
Parkinson's PT management
PPTX
Parkinson's Disease [Advanced Pharmacology]
PDF
Movement disorders emergencies
Pharmacotherapy of parkinson disease
Management of parkinson’s disease
PARKINSON’S DISEASE
Management of early and advanced parkinson disease
Parkinsons disease
Immune mediated extrapyramidal disorders
PARKINSON DISEASE
Advances in Management of Parkinson's Disease
Parkinson’s disease clinical research challenges and best practices 2015
Management of parkinson’s disease
Extra-nigral motor scenarios in Parkinson Disease
Neuropsychiatric Symptoms of Parkinson Disease
Invega
Management of advanced Parkinson's Disease. dr. Walid Reda Ashour, MD
Parkinson\'s Disease
Parkinson's disease n management
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Parkinson's PT management
Parkinson's Disease [Advanced Pharmacology]
Movement disorders emergencies
Ad

Viewers also liked (20)

PPT
Peds Ocd
PPT
Thalamus by DR.ARSHAD
PPTX
PPT
Regolazione ipotalamica del sonno e ritmo circadiano
PPT
OCD Action - Making CBT work - Paul Salkovskis
PDF
แนวทางการรักษาผู้ป่วยความดันโลหิต ของรพ.พิมาย
PPTX
Patricia Perrin - CBT for OCD Characterized Primarily By Intrusive Thoughts, ...
PPTX
Etiology of OCD
PPTX
A presentation on opportunities of new advances psychology that creates new h...
PPTX
2 psychiatric research
PDF
Presenatatie ocd escap 2015 t5 david mataix_cols_escap_madrid_keynote_2015_final
PPTX
Borderline personality disorder
PPTX
Etiopathogenesis of bipolar disorder
PPT
Cbt -Ocd
PPT
OCD Action - Guided Self Help – Karina Lovell
PPTX
Treating Treatment Refractory Depression With TMS
PPT
Bipolar Disorder[1]
PPT
Psychoanalyticppt
PPTX
IIT(BHU) Dirty Quiz-Prelims
PPT
Recent advances in Eating disorder
Peds Ocd
Thalamus by DR.ARSHAD
Regolazione ipotalamica del sonno e ritmo circadiano
OCD Action - Making CBT work - Paul Salkovskis
แนวทางการรักษาผู้ป่วยความดันโลหิต ของรพ.พิมาย
Patricia Perrin - CBT for OCD Characterized Primarily By Intrusive Thoughts, ...
Etiology of OCD
A presentation on opportunities of new advances psychology that creates new h...
2 psychiatric research
Presenatatie ocd escap 2015 t5 david mataix_cols_escap_madrid_keynote_2015_final
Borderline personality disorder
Etiopathogenesis of bipolar disorder
Cbt -Ocd
OCD Action - Guided Self Help – Karina Lovell
Treating Treatment Refractory Depression With TMS
Bipolar Disorder[1]
Psychoanalyticppt
IIT(BHU) Dirty Quiz-Prelims
Recent advances in Eating disorder
Ad

Similar to Ocd santhosh final (20)

PPTX
Obsessive Compulsive Disorder Diagnosis and Management
PDF
OCD.pdf
PPTX
PPTX
Obsessive Compulsive Disorder treatment update.pptx
PPTX
OCD.pptx
PPTX
PPTX
OCD seminar Dr. Manish Singh-1.pptx
PPTX
Obsessive Compulsive Disorder (OCD)
PPT
Obsessive compulsive disorder
PPTX
Ocd pathophysiology & updated treatment
PPTX
Obsessive-Compulsive disorder
PDF
Obsessive Compulsive Disorder | Psychiatric Nursing | Juhin J
PPTX
obsessivecompulsivedisorder- OCD presentation
PPT
OBSESSIVE COMPULSIVE DISORDER (OCD)
PPTX
obsessive compulsive disorder
PPTX
seminar obssesive compulsive disorder .pptx
PPT
Dra. Naomi A. Fineberg - Simposio Internacional ' La enfermedad de la duda: e...
DOCX
Your Project in pages discuss.docx
PPTX
BRAIN STIMULATION METHODS IN OCD
Obsessive Compulsive Disorder Diagnosis and Management
OCD.pdf
Obsessive Compulsive Disorder treatment update.pptx
OCD.pptx
OCD seminar Dr. Manish Singh-1.pptx
Obsessive Compulsive Disorder (OCD)
Obsessive compulsive disorder
Ocd pathophysiology & updated treatment
Obsessive-Compulsive disorder
Obsessive Compulsive Disorder | Psychiatric Nursing | Juhin J
obsessivecompulsivedisorder- OCD presentation
OBSESSIVE COMPULSIVE DISORDER (OCD)
obsessive compulsive disorder
seminar obssesive compulsive disorder .pptx
Dra. Naomi A. Fineberg - Simposio Internacional ' La enfermedad de la duda: e...
Your Project in pages discuss.docx
BRAIN STIMULATION METHODS IN OCD

Recently uploaded (20)

PDF
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
PPTX
09. Diabetes in Pregnancy/ gestational.pptx
PPTX
Reading between the Rings: Imaging in Brain Infections
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PDF
Transcultural that can help you someday.
PPTX
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
focused on the development and application of glycoHILIC, pepHILIC, and comm...
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
Electrolyte Disturbance in Paediatric - Nitthi.pptx
Lecture 8- Cornea and Sclera .pdf 5tg year
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
Vaccines and immunization including cold chain , Open vial policy.pptx
Acute Coronary Syndrome for Cardiology Conference
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Radiation Dose Management for Patients in Medical Imaging- Avinesh Shrestha
09. Diabetes in Pregnancy/ gestational.pptx
Reading between the Rings: Imaging in Brain Infections
neurology Member of Royal College of Physicians (MRCP).ppt
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
Transcultural that can help you someday.
IMAGING EQUIPMENiiiiìiiiiiTpptxeiuueueur

Ocd santhosh final

  • 1. Biological treatments of OCD Dr.S.Santhosh Goud Chairperson;Dr.Ravi Awchar
  • 2. DSM 5-OCD and related disorders • OCD • BDD • Hoarding disorder • Trichitillo mania/HPD • Excoriation/skin picking disorder • Substance/medication induced OCD • OCD due to another medical condition
  • 3. Ocd criteria DSM 5 criteria • Presence of obsession/compulsion • Time consumption>1 hr/clinically significant distress or impairment • Rule out role of substance/other medical condition • Not due to other mental disorder
  • 4. • Obsessions are persistent, uncontrollable thoughts, impulses, or images that are intrusive, unwanted and disturbing. They cause anxiety or discomfort that significantly interferes with normal life • Individuals who have OCD feel compelled to perform repetitive actions called compulsions, or rituals, in an attempt to relieve the distress caused by the obsessions
  • 5. Neuro biology of OCD Emotional brain controls the reasoning brain The part of the brain responsible for ocd, functions very much on the same emotional level as that of a two year old. Reasoned argument is, therefore, pointless…!
  • 6. Loss of filtering • Thalamus-sensory gating • Caudate nuleus-thought filtering
  • 7. • Orbito frontal cortex-combines thoughts and emotions • Cingulate gyrus in the middle of brain • Helps in shifting attention from one thought/behavior to another • CG also acts as a signaling center for danger so forces to do compulsion
  • 9. Structural changes • Volume reduction of the OFC • Cingulate cortex • Decreased OFC with increased thalamic volume constant finding in refractory cases
  • 10. Functional studies • FDG-PET increased glucose metabolism in ofc,caudate,thalamus,pfc and acc
  • 11. Neurotransmitter changes • Serotonin • Autoreceptors (5HT1D) require higher SSRI dose • Role of 5HT 7 receptors Dopamine • Quinpirole treated rats-compulsive checking
  • 12. Glutamate • OCD is a hyperglutaminergic state of prefrontal brain-(Carlsson) • SSRI, Clomipramine do regulate this Glutamate regulators used in resistant cases
  • 13. Neuroimmunology • Auto immunity to basal ganglia • Sydenham chorea, PANDAS • D8/17 B lymphocyte antigen more prone • Plasmapheresis, iv immunogloblin useful
  • 14. Genetics • Higher concordance in monozygotic twins • 5HTTLPR • Role of DRD4 variant • COMT variation • polymorphisms of MAOA genes
  • 15. Course and prognosis • Adolescent onset~65% • <15% after 35 yrs of age • Nearly 70 percent of patients report a continuous course of symptoms, and 23 percent experience a waxing and waning course • Average time to treatment after meeting diagnostic criteria for OCD is 11 years (The Brown Longitudinal Obsessive
  • 16. Naturalistic follow up studies from pre-sri/cbt era • Improvement in 66% recovery in 32% (lewis,1936) Pollitt study-101 patients • 3 months-15yrs(mean 3.4yrs) out come • 34 leucotomized • 67 non leucotomized • 40% good response;most of them with in 2 years • Most of the patients having waxing waning
  • 17. • Skoog &skoog study 1999 • 250 patients admitted between 1947-1953 • Reexamined between 1989-1993 • 75 died,32 lost follow up • 144 patients data could be collected • Shneiders ocd criteria
  • 18. • Improvement in 83% • Recovery 48% • Complete recovery 20% subclinical symptoms 28% • 38% recovered in first decade • Hal of them had illness for >30yrs
  • 19. Recent studies • Full remission 20-45%(Y-BOCS <3) • Partial remission 20-55%( 4-14) • Clinical ocd10-60%(>15)
  • 20. • 40-60% unsatisfactory response • Predictors of treatment response..?
  • 21. • Hoarding disorder poor response to SSRI • High scores on sexual/religious obsessions poor response to SRI/CBT(Matix-colas et al) • Somatic obsessions had poorer insight and less response to drugs(expect MAO-I)
  • 23. FDA approved drugs • Anafranil (clomipramine)-c10 • Prozac (fluoxetine)-c7 • Luvox (fluvoxamine)-c8 • Paxil (paroxetine hydrochloride) • Zoloft (sertraline)-c6
  • 24. “Off-label" OCD medications • Celexa (citalopram) • Lexapro (escitalopram) • Effexor (venlafaxine) • Cymbalta (duloxetine) • Remeron (mirtazapine)
  • 25. Augmenting agents • Antipsychotic medications(Risperdal (risperidone)Zyprexa (olanzapine)Seroquel (quetiapine)) • Other augmenting agents • B blocker • 5HT1 agonist • Ondansetron • Riluzole • Memantine
  • 26. How to choose the right drug • Diagnosis;severity;comorbid illness • Medical history;the potential side effects of each medication, and the possibility of an adverse interaction with another drug the person is taking
  • 27. drug Starting dose Target dose(mg/day ) Usual Maximum dose Occassional max dose Fluoxetine 20 40-60 80 120 Sertraline 50 200 200 400 Fluvoxamine 50 200 300 450 Paroxetine 20 40-60 60 100 escitalopram 10 20 40 60 clomipramine 25 100-250 300
  • 28. Resistence vs refractoriness • Rauch and Jenike, in 1994, established the difference between "resistant" and "refractory" patients. • They defined as "resistant" those who participate in a trial with any first-line therapy and do not have a satisfactory response, while the "refractory" patients are those who do not respond appropriately to several treatments administered in an adequate manner
  • 29. • Pallanti et al • No response -<25% reduction in YBOCS score CGI-I 4 • Refractory- failure to respond to all available treatments • Pseudo resistance..?
  • 30. Predictors of treatment non-response • Early age of onset • Longer ocd • Mixed ocd • Sexual obsessions • Washing compulsons • Hoarding • Poor insight • Schizotypal pd
  • 31. • Switching to another SSRI(~50%) • Switch to Clomipramine(upto300mg) (min 2 SSRI trails;NIMHANS ocd clinic) • IV Clomipramine (~43%) • Min 14 infusions • 250mg/day • More side effects
  • 32. • SSRI to venlafaxine or Mirtazepine Augmentation • Best evidence with Risperidone(0.5-6mg) • First doc for augmentation • Other drugs haloperidol(1.5- 5mg),olanzepine(2.5-20),quetiapine(50- 300) • Clonazepam(upto 6.5mg) • Buspirone(60-90mg),
  • 33. • Nicotine,cbzp,lamotrigene,gabapentine, reboxetine,psychostimulants,nac, Aripiprazole less evidence • Lithium, thyroid,l-tryptophan(2gm) ineffective;useful for comorbidities • once-weekly oral morphine sulfate • Other less well-supported monotherapies include dextroamphetamine (Dextrostat), tramadol (Ultram), monoamine oxidase inhibitors, ondansetron (Zofran)
  • 34. • When to change augmentation? • no desired response by 6-8wks • Augmentation for how long?
  • 35. Combination strategies • SSRI and clomipramine • Superior to switching(Pallanti et al) • Look for serotonin syndrome
  • 36. Intensive residential therapy • IP treatment • Multidisciplinary approach • Pharmacotherapy • Daily CBT 2-4 hours • Group therapy
  • 39. Other somatic therapies • r-TMS • DBS • ECT • Vagal stimulation
  • 40. r-TMS • Since 1997, in published trials, a total of 110 OCD patients have been treated with rTMS • Greenberg et al.inhibition of the prefrontal activity with rTMS might reduce obsessive-compulsive symptoms.
  • 41. • 1) stimulation of the dorsolateral prefrontal cortex (DLPFC) • 2) inhibition of the orbitofrontal cortex (OFC) directly • 3) inhibition of the supplementary motor area (SMA).
  • 42. Deep brain stimulation • Nucleus accumbens • Anterior capsule • Caudate nucleus • Subthalamic nucleus
  • 43. ECT • The primary indication would be the severe depression with which intractable OCD is often associated(Bulletin of Clinical Psychopharmacology • ECT Use in Refractory Obsessive-Compulsive Disorder Nesrin B. Tomruk Omer Saatcioglu)
  • 45. Neurosurgical procedures Criteria • Diagnosis by standard criteria • Severe ocd • Long standing(>5 yrs) • At least 3 serotenergic(one should be clomipramine),2 augmenting agents, for 12 weeks • Adequate cbt (20hrs) • Less than 25% improvement with treatment
  • 46. Procedures • Anterior capsulotomy • Anterior cingulotomy • Subcaudate tractotomy • Limbic leukotomy(subcaudate tractotomy with anterior cingulotomy) Gamma knife capsulotomy safer and non- invasive
  • 47. Further reading on psycho surgery in OCD • Indian J Psychiatry. 2009 Jul-Sep; 51(3): 216–221 Surgical treatment of obsessive compulsive disorders: Current status Paresh K. Doshi

Editor's Notes

  • #2: 4th most common psychiatric condition(phobias,substance use, mdd) prevalance1.9%-3.3%(~1.6)
  • #4: Dd-gad, bdd,hoardind,hair pilling,skin pricking,stereotypic movement disorder,eating disorder,addictive disorder,illness anxiety disorder,paraphilias,impulse control disorder,schiz,asd, ocpd
  • #6: the Thalmus processes sensory images coming to the brain from the rest of the body, while the Caudate Nucleus, part of the Basal Gangli in the centre of the brain controls and sorts sensory information and does thought filtering.  When these messages are being misinterpreted, ‘misfiring’, the thinking part of the brain is naturally confused and is responding chemically to a threat perceived by the primitive, non-reasoning part of the brain with rational doubt of the threat’s danger, but a major need to response as if the danger is real. In effect, the Caudate Nucleus is letting unnecessary thoughts and impulses through to the Cortex where the thoughts and emotions combine; and an over active Cingulate Nucleus at the brain’s centre, which helps shift attention from one thought or behaviour to another, becomes over active and gets stuck on certain behaviours, thoughts or ideas. The Cingulate is that part of the brain which tells the OCD sufferer that something terrible will happen if the compulsions are not carried out.
  • #7: In ocd cd losts the filtering functions;allows unnecessary thoughts n urges works as a poor doorman There is a convergence of evidence implicating the corticostriatothalamocortical (CSTC) loop involving orbitofrontal (OFC) cortex, anterior cingulated cortex (ACC) and basal ganglia as central to the pathophysiology of OCD.[4–6] Two distinct routes are conceptualized from the striatum to the thalamus; the so-called “direct” and “indirect” pathways. The direct pathway projects from the cortex to the striatum to the internal segment of globus pallidus and substantia nigra to the thalamus and then back to the cortex. The indirect pathway is similar from the cortex to the striatum but then projects to the external segment of the globus pallidus to the subthalamic nucleus, before returning to the internal segment of the the globus pallidus/substantia nigra, there joining the direct pathway to the thalamus and projecting back to the cortex. Impulses transmitted via the direct pathway disinhibit the thalamus, presumably resulting in a release of behaviors as necessary for an adaptive function. Activity in the indirect pathway inhibits the thalamus, resulting in the cessation of ongoing behavioral routine. The prevailing theory on OCD suggests that a hitherto unknown primary striatal pathologic process underlies a relative imbalance favoring striatothalamic inhibition leading to hyperactivity within OFC and ACC, the caudate nucleus (CN) and the thalamus
  • #8: Ofc tells us when something is wrong an when something should be avoided like an early warning system In ocd it does overtime In ocd cg becomes overactive
  • #10: Volume reduction proportionate to severity of illness
  • #12: Ht7 antagonism results in decreased oc syptoms
  • #13: Glu regulators are topiramate,riluzole n d-cycloserine
  • #15: seretonin transporter gene(5httlpr)
  • #21: When the initial treatment is unsatisfactory, several factors may be contributing to the lack of improvement: interference by concomitant conditions, inadequate patient adherence to the treatment plan, the presence of psychosocial stressors, the family&amp;apos;s degree of accommodation for the patient&amp;apos;s symptoms, and the patient&amp;apos;s inability to tolerate psychotherapy or medication.
  • #24: CMI was first used in 1968 by Reynghe de voxrie
  • #27: should all be considered when deciding which medication to use Y-BOCs, Maudsley oc inventory, brown assessment of beliefs, Responsibility attitude scale, CGI scale
  • #28: Some patients may need to start at one half of this dosage or less to minimize undesired side effects such as nausea or to accommodate anxiety about taking medication. CMI less than 150mg subtherapeutic These dosages are sometimes used for rapid metabolizers or for patients with no or mild side effects and inadequate therapeutic response after eight weeks or more at the usual maximal dosage. Combined plasma levels of clomipramine plus desmethylclomipramine 12 hours after dosing should be kept below 500 ng per mL to minimize risk of seizures and cardiac conduction delay. Sertraline is better absorbed with food
  • #30: Trd defined by thase n rush treat,ment guidelines for trd fleck and horwath- optimization of dose,switching to another first line approach,augmentation,combination
  • #33: One study had shon 76% benefit in ssri non-responsers But if the pt not responded to paroxetine then venlaf not useful
  • #35: Relapse rate of 83% with in first 2 months after stoppinh augmentation;so better to continue with primary drug
  • #36: Aim for clomipramine levels of 225-350 ng/ml and combined clomipramine and desmethylclomipramine levels of &amp;lt; or = to 500 ng/ml in blood samples drawn about 12 hours after a dose; steady state takes two to three weeks to achieve
  • #37: Massachusetts irt study administered for 3 months 30% improvement in ybocs score
  • #41: They applied rTMS (80% motor threshold, 20 Hz for 2 s/min) for 20 min to 12 patients with OCD and found significantly decreased compulsive urges for 8 h after stimulation
  • #42: The SMA was chosen as a useful target for rTMS because it has extensive connections with regions implicated in cognitive processes and motor control
  • #44: ECT has occasionally been used for the treatment of anxiety disorders and currently no existing guideline considers anxiety disorders as a primary indication for ECT
  • #47: Kumud Chawla Gamma Knife Centre in India :The 1st Centre of Gamma Knife Radiosurgery In India